GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | SLC22A16 | increases uptake | EXP | | 6480464 | CTD | SLC22A16 protein results in increased uptake of Tetraethylammonium | PMID:15963465 | SLC22A16 | multiple interactions | EXP | | 6480464 | CTD | [Tetraethylammonium results in decreased activity of SLC22A16 protein] which results in decreased susceptibility to Doxorubicin; Dopamine inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium]; Guanidine inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium]; Lidocaine inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium]; N(1)-methylnicotinamide inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium]; Procainamide inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium]; Serotonin inhibits the reaction [SLC22A16 protein results in increased uptake of Tetraethylammonium] | PMID:15963465 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |